SFM
NVAX icon

Sphera Funds Management’s Novavax NVAX Stock Holding History

Sphera Funds Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-20,000
Closed -$3.36M – 109
2015
Q4 		$3.36M Buy
20,000
+12,500
+167% +$1.92M 0.49% 48
2015
Q3 		$1.06M Buy
+7,500
New +$1.68M 0.14% 117
2015
Q1 		– Sell
-77
Closed -$9K – 162
2014
Q4 		$9K Buy
+77
New +$8.05K ﹤0.01% 124

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Sphera Funds Management's NVAX Position: Q1 2016 in Review

Sphera Funds Management sold out of Novavax (NVAX) in Q1 2016, closing a stake of 20,000 shares — an estimated $3.36M sold.

Sphera Funds Management first reported a position in NVAX in Q4 2014 and held it in 3 quarters. The position peaked at $3.36M in Q4 2015. 175 funds tracked by Wall St. Rank hold NVAX as of Q1 2016.

  • Sphera Funds Management reported no remaining Novavax position as of Q1 2016 after selling out during the quarter.
  • Sphera Funds Management sold 20,000 Novavax shares in Q1 2016, an estimated $3.36M.
  • Sphera Funds Management first reported a position in Novavax in Q4 2014 and held it in 3 quarters.
  • Sphera Funds Management's Novavax position peaked at $3.36M in Q4 2015.
  • 175 funds tracked by Wall St. Rank held Novavax as of Q1 2016.

Based on Sphera Funds Management's 13F filing for Q1 2016, filed 16 May 2016.